Table 1 Changes in each parameter are evaluated before and after administration of aliskiren (150 mg per day, every other day, for 2 months) in 31 hypertensive subjects with advanced diabetic nephropathy
Before | After | % Change | |
|---|---|---|---|
Urinary | |||
MCP-1 (pg mg−1 Cre) | 503.3 (54.9–3144.0) | 359.3 (38.8–2527.0)* | −24.1±5.0 |
IL-6 (pg mg−1 Cre) | 4.7 (0.2–36.5) | 2.6 (0.2–18.5)* | −29.6±7.3 |
8-OHdG (ng mg−1 Cre) | 8.5 (4.3–17.5) | 6.6 (4.4–14.8)* | −16.7±5.2 |
ACR (μg mg−1 Cre) | 1320.5 (429.8–3427.9) | 841.6 (184.3–3783.1)* | −25.6±6.7 |
SBP (mm Hg) | 145.2±2.8 | 135.8±3.1* | −6.3±1.5 |
eGFR (ml min−1) | 45.3±2.2 | 51.1±2.5* | 14.3±3.4 |